AWHONN Statement on FDA Committee Recommendation FDA Withdraw of 17p alpha Hydroxyprogesterone Caproate, 17-OHPC (Makena)
The Food and Drug Administration (FDA) had a hearing on October 19, 2022 on the Center for Drug Evaluation and Research's (CDER) proposal to withdraw FDA approval for 17p hydroxyprogesterone Caproate injection, 17-OHPC Makena), 250 milligrams [...]